Financhill
Back

Verrica Pharmaceuticals Vs. Zevra Therapeutics Industry Stock Comparison

Sell
25

VRCA
Verrica Pharmaceuticals

Last Price:
1.94
Seasonality Move:
-10.89%
Buy
53

ZVRA
Zevra Therapeutics

Last Price:
8.03
Seasonality Move:
-17.07%
Sell
25
Verrica Pharmaceuticals (VRCA) is a Sell

Is Verrica Pharmaceuticals a Buy, Sell or Hold?

  • The current Verrica Pharmaceuticals [VRCA] share price is $1.94. The Score for VRCA is 25, which is 50% below its historic median score of 50, and infers higher risk than normal.
  • VRCA is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
53
Zevra Therapeutics (ZVRA) is a Buy

Is Zevra Therapeutics a Buy, Sell or Hold?

  • The current Zevra Therapeutics [ZVRA] share price is $8.04. The Score for ZVRA is 53, which is 6% above its historic median score of 50, and infers lower risk than normal.
  • ZVRA is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

VRCA Stock Price Chart

What is Verrica Pharmaceuticals's stock price today?

  • The Verrica Pharmaceuticals share price today is $1.94
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and VRCA is experiencing slight buying pressure.

ZVRA Stock Price Chart

What is Zevra Therapeutics's stock price today?

  • The Zevra Therapeutics share price today is $8.04
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ZVRA is experiencing slight selling pressure.

VRCA Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.67 Sell
Relative Strength Index (14 RSI): 26.9 Sell
Chaikin Money Flow: 25376 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (1.91 - 2.71) Sell
Bollinger Bands (100): (3.74 - 8.76) Sell

ZVRA Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.26 Buy
Relative Strength Index (14 RSI): 63.88 Buy
Chaikin Money Flow: -92956 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (7.15 - 7.67) Buy
Bollinger Bands (100): (4.62 - 7.06) Buy

VRCA Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 1.91 Buy
20-day SMA: 2.17 Sell
50-day SMA: 4.45 Sell
200-day SMA: 5.98 Sell
8-day EMA: 1.94 Buy
20-day EMA: 2.39 Sell
50-day EMA: 3.88 Sell
200-day EMA: 5.53 Sell

ZVRA Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 7.65 Buy
20-day SMA: 7.43 Buy
50-day SMA: 6.97 Buy
200-day SMA: 5.76 Buy
8-day EMA: 7.7 Buy
20-day EMA: 7.46 Buy
50-day EMA: 6.9 Buy
200-day EMA: 5.87 Buy

Verrica Pharmaceuticals Earnings Growth & VRCA Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.09 per share, and an increase next year of $0.68 per share.

Zevra Therapeutics Earnings Growth & ZVRA Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.10 per share, an increase next quarter of $0.29 per share, a decrease this year of $0.35 per share, and an increase next year of $1.14 per share.

Verrica Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Zevra Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):